Suppr超能文献

肿瘤演进模型中的肿瘤内异质性。

Intratumor heterogeneity in evolutionary models of tumor progression.

机构信息

Department of Mathematics, Duke University, Durham, North Carolina 27708, USA.

出版信息

Genetics. 2011 Jun;188(2):461-77. doi: 10.1534/genetics.110.125724. Epub 2011 Mar 15.

Abstract

With rare exceptions, human tumors arise from single cells that have accumulated the necessary number and types of heritable alterations. Each such cell leads to dysregulated growth and eventually the formation of a tumor. Despite their monoclonal origin, at the time of diagnosis most tumors show a striking amount of intratumor heterogeneity in all measurable phenotypes; such heterogeneity has implications for diagnosis, treatment efficacy, and the identification of drug targets. An understanding of the extent and evolution of intratumor heterogeneity is therefore of direct clinical importance. In this article, we investigate the evolutionary dynamics of heterogeneity arising during exponential expansion of a tumor cell population, in which heritable alterations confer random fitness changes to cells. We obtain analytical estimates for the extent of heterogeneity and quantify the effects of system parameters on this tumor trait. Our work contributes to a mathematical understanding of intratumor heterogeneity and is also applicable to organisms like bacteria, agricultural pests, and other microbes.

摘要

除了极少数例外,人类肿瘤起源于单个细胞,这些细胞积累了必要数量和类型的可遗传改变。每个这样的细胞都会导致失调的生长,最终形成肿瘤。尽管它们具有克隆起源,但在诊断时,大多数肿瘤在所有可测量的表型中都显示出明显的肿瘤内异质性;这种异质性对诊断、治疗效果和药物靶点的识别都有影响。因此,了解肿瘤内异质性的程度和演变具有直接的临床意义。在本文中,我们研究了在肿瘤细胞群体指数增长过程中出现的异质性的进化动态,其中可遗传的改变赋予细胞随机的适应性变化。我们获得了对异质性程度的分析估计,并量化了系统参数对这一肿瘤特征的影响。我们的工作有助于对肿瘤内异质性的数学理解,也适用于细菌、农业害虫和其他微生物等生物体。

相似文献

1
Intratumor heterogeneity in evolutionary models of tumor progression.
Genetics. 2011 Jun;188(2):461-77. doi: 10.1534/genetics.110.125724. Epub 2011 Mar 15.
2
Evolutionary dynamics of intratumor heterogeneity.
PLoS One. 2011 Mar 30;6(3):e17866. doi: 10.1371/journal.pone.0017866.
3
Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Am J Physiol Cell Physiol. 2021 May 1;320(5):C750-C760. doi: 10.1152/ajpcell.00575.2020. Epub 2021 Mar 3.
4
Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
Oncotarget. 2016 Mar 1;7(9):10051-63. doi: 10.18632/oncotarget.7067.
5
Intra-tumour heterogeneity - going beyond genetics.
FEBS J. 2016 Jun;283(12):2245-58. doi: 10.1111/febs.13705. Epub 2016 Apr 1.
7
A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.
Pathobiology. 2018;85(1-2):7-17. doi: 10.1159/000477813. Epub 2017 Jul 28.
8
Multiregional Tumor Trees Are Not Phylogenies.
Trends Cancer. 2017 Aug;3(8):546-550. doi: 10.1016/j.trecan.2017.06.004. Epub 2017 Jul 17.
9
Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies.
Trends Cancer. 2020 Jan;6(1):13-19. doi: 10.1016/j.trecan.2019.11.010. Epub 2020 Jan 3.
10
Evolution of phenotypic plasticity leads to tumor heterogeneity with implications for therapy.
PLoS Comput Biol. 2024 Aug 9;20(8):e1012003. doi: 10.1371/journal.pcbi.1012003. eCollection 2024 Aug.

引用本文的文献

1
Accumulation of Oncogenic Mutations During Progression from Healthy Tissue to Cancer.
Bull Math Biol. 2024 Oct 29;86(12):142. doi: 10.1007/s11538-024-01372-3.
3
Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation.
Cancers (Basel). 2022 Nov 30;14(23):5930. doi: 10.3390/cancers14235930.
5
Simulating the Dynamic Intra-Tumor Heterogeneity and Therapeutic Responses.
Cancers (Basel). 2022 Mar 24;14(7):1645. doi: 10.3390/cancers14071645.
6
Delineating the evolutionary dynamics of cancer from theory to reality.
Nat Cancer. 2020 Jun;1(6):580-588. doi: 10.1038/s43018-020-0079-6. Epub 2020 Jun 22.
7
Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer.
Endocrinology. 2021 Dec 1;162(12). doi: 10.1210/endocr/bqab208.
8
Grading of endometrial cancer using H HR-MAS NMR-based metabolomics.
Sci Rep. 2021 Sep 13;11(1):18160. doi: 10.1038/s41598-021-97505-y.
9
Elements and evolutionary determinants of genomic divergence between paired primary and metastatic tumors.
PLoS Comput Biol. 2021 Mar 17;17(3):e1008838. doi: 10.1371/journal.pcbi.1008838. eCollection 2021 Mar.
10
Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Am J Physiol Cell Physiol. 2021 May 1;320(5):C750-C760. doi: 10.1152/ajpcell.00575.2020. Epub 2021 Mar 3.

本文引用的文献

1
Accumulation of driver and passenger mutations during tumor progression.
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50. doi: 10.1073/pnas.1010978107. Epub 2010 Sep 27.
2
Evolutionary dynamics of tumor progression with random fitness values.
Theor Popul Biol. 2010 Aug;78(1):54-66. doi: 10.1016/j.tpb.2010.05.001. Epub 2010 May 19.
3
Evolution of resistance and progression to disease during clonal expansion of cancer.
Theor Popul Biol. 2010 Feb;77(1):42-8. doi: 10.1016/j.tpb.2009.10.008. Epub 2009 Nov 5.
4
Stem cell concepts renew cancer research.
Blood. 2008 Dec 15;112(13):4793-807. doi: 10.1182/blood-2008-08-077941.
5
Beneficial fitness effects are not exponential for two viruses.
J Mol Evol. 2008 Oct;67(4):368-76. doi: 10.1007/s00239-008-9153-x. Epub 2008 Sep 9.
6
The evolution of two mutations during clonal expansion.
Genetics. 2007 Dec;177(4):2209-21. doi: 10.1534/genetics.107.078915.
7
Genetic progression and the waiting time to cancer.
PLoS Comput Biol. 2007 Nov;3(11):e225. doi: 10.1371/journal.pcbi.0030225.
8
Clonal interference in large populations.
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18135-40. doi: 10.1073/pnas.0705778104. Epub 2007 Nov 5.
9
Breast tumor heterogeneity: cancer stem cells or clonal evolution?
Cell Cycle. 2007 Oct 1;6(19):2332-8. doi: 10.4161/cc.6.19.4914. Epub 2007 Aug 17.
10
Molecular definition of breast tumor heterogeneity.
Cancer Cell. 2007 Mar;11(3):259-73. doi: 10.1016/j.ccr.2007.01.013.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验